Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEXT: Exemestane Plus GnRH Analogue As Adjuvant Therapy For Premenopausal Women With Endocrine Responsive Breast Cancer
NCT00066703Phase 3Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Nov 2003
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by ETOP IBCSG Partners Foundation. Started Nov 2003; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00066703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066703.